News

Monogram Orthopaedics Secures First Conditional Purchase Order to Initiate Pilot Program with Global Distributor

Moves from R&D to CommercializationAUSTIN, TX / ACCESSWIRE / July 18, 2023 / Monogram Orthopaedics Inc., (NASDAQ:MGRM) ("Monogram" or the…

11 months ago

Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML

Phase 2 Trials in Relapsed/Refractory and Frontline Settings Planned, APVO436 to be administered in Combination with Emerging Standard of CareNew…

11 months ago

NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023

FT. MYERS, FL / ACCESSWIRE / July 18, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and…

11 months ago

M2 Information Systems Launches Revolutionary IRIS Family Messaging: Reinventing Communication in Healthcare Settings

A Leader in Developing Cutting-Edge Hospital Applications, M2 Information Systems Launches IRIS Family Messaging to Help Streamline Communication & Foster…

11 months ago

USOSM Launches Oral and Maxillofacial Surgery Centers of Excellence

Industry First Program to Recognize, Stimulate Clinical Excellence, Exceptional Patient Care and Practice GrowthIRVING, Texas, July 18, 2023 (GLOBE NEWSWIRE)…

11 months ago

Celularity Human Placental-Derived Advanced Biomaterials Demonstrate Superior Biocompatibility and Better Support Differentiated Cell Functions in Studies

Celularity will present benchtop and clinical case studies suggesting the therapeutic potential of its human placental-derived biomaterials at ICBST23, the…

11 months ago

Petalfast Partners with Lime to Bring “Affordable, Effective & Loud” Cannabis to California Consumers

IRVINE, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Petalfast, a route-through-market platform for the cannabis industry, announced its partnership with…

11 months ago

BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder

ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…

11 months ago

Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2023 Results and Participation in Upcoming Investor Conference

SANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and…

11 months ago

Cepham’s Prosprune Protects Men and Sustains the Environment in the Name of Prostate Health

Developing Prosprune® Recognizing the need for an alternative to the endangered Pygeum africanum, the research team at Cepham analyzed various…

11 months ago